Table 2.
Author | Cell origin | Cell characterization | Animal model | Scaffold | Observation time | Analytic method | Outcome |
---|---|---|---|---|---|---|---|
Brocher et al. [27] | Human | Adherence, CD105+, CD73+, CD90+, CD34−, CD45− | Subcutaneous in mice | TCP granules | 8 weeks | Histology (new bone observed in specimens) | A-CEAC: 0/22 BM-CEAC: 11/14 |
12 weeks | A-CEAC 2/6 BM-CEAC 5/6 |
||||||
| |||||||
Hayashi et al. [28] | Rat | Adherence, CD90+, CD29+, CD45− | Subcutaneous | HA disk | 6 weeks | μCT (bone volume) | A-CEACa 0.05 mm3 ± 0.05 BM-CEAC 6.85 mm3 ± 1.89 (p < 0.001) |
Histology (new bone observed in specimens) | A-CEAC: none BM-CEAC: all |
||||||
| |||||||
Jo et al. [29] | Human | Adherence, CD105+, CD73+, CD90+, CD34−, CD45−, HLA-DR- | Segmental femur defect in rat | HA/TCP (60%/40%) cylinder | 12 weeks | X-ray (bone formation score [30]) | BM-CEACb: 4.00 ± 0.63 A-CEACb: 3.17 ± 0.75 (n.s.) |
CT (BV/TV) | BM-CEAC: 14.2% ± 1.4 A-CEAC: 10.4% ± 1.2 (p < 0.05) |
||||||
| |||||||
Kang et al. [31] | Dog | Adherence, CD73+, CD90+, CD44+, CD34−, CD45−, CD14− | Segmental radius defect | TCP/PLGC | 20 weeks | X-ray (radiographic healing) | BM-CEACc: 7/8 A-CEACc: 6/8 |
Histomorphometry (BV/TV) | A-CEAC: 33.90% ± 4.31 BM-CEAC: 33.56% ± 8.09 (n.s.) |
||||||
| |||||||
Liao and Chen [13] | Human | Adherence | Spinal fusion in rats | Collagen sponge | 8 weeks | μCT (BV/TV) | Insignificant difference between A-CEACd and BM-CEACd |
Histology (description) | No bridging observed in A-CEAC or BM-CEAC groups | ||||||
| |||||||
Niemeyer et al. [18] | Sheep | Adherence, differentiation into bone/cartilage/fat | Segmental tibia defect | Mineralized collagen type I | 26 weeks | X-ray (relative bone area in defect) | A-CEAC inferior to BM-CEAC (p < 0.05)e |
Histomorphometry (BV/TV) | A-CEAC inferior to BM-CEAC (p < 0.01) | ||||||
| |||||||
Wen et al. [32] | Human | Adherence CD105+, CD90+, CD29+, CD44+, CD34−, differentiation into bone/fat | Calvarial defect in rats | Collagen gel | 8 weeks | X-ray (average grey level) | Insignificant difference between A-CEAC and BM-CEAC |
| |||||||
This study | Sheep | Adherence | Subcutaneous in mice | HA granules | 8 weeks | Histomorphometry (BV/TV) | A-CEAC: 1.78% ± 0.91 BM-CEAC: 20.87% ± 3.70 (p < 0.0017)f |
aA-CEAC from pellet shown here, bundifferentiated groups shown here, ctime to healing was not significant, dtransfected with LacZ reporter gene; data available only in figure, edata available only in figure, and f p value corresponds to p < 0.01 prior to Bonferroni correction.